Organovo Holdings Inc
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with … Read more
Organovo Holdings Inc (ONVO) - Net Assets
Latest net assets as of December 2024: $364.00K USD
Based on the latest financial reports, Organovo Holdings Inc (ONVO) has net assets worth $364.00K USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.84 Million) and total liabilities ($3.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $364.00K |
| % of Total Assets | 9.47% |
| Annual Growth Rate | N/A |
| 5-Year Change | -86.48% |
| 10-Year Change | -92.61% |
| Growth Volatility | 33.95 |
Organovo Holdings Inc - Net Assets Trend (2011–2024)
This chart illustrates how Organovo Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Organovo Holdings Inc (2011–2024)
The table below shows the annual net assets of Organovo Holdings Inc from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $3.60 Million | -76.51% |
| 2023-03-31 | $15.33 Million | -49.26% |
| 2022-03-31 | $30.21 Million | -22.93% |
| 2021-03-31 | $39.20 Million | +47.18% |
| 2020-03-31 | $26.63 Million | -26.63% |
| 2019-03-31 | $36.30 Million | -18.59% |
| 2018-03-31 | $44.59 Million | -28.50% |
| 2017-03-31 | $62.36 Million | +0.29% |
| 2016-03-31 | $62.18 Million | +27.69% |
| 2015-03-31 | $48.70 Million | +0.85% |
| 2014-03-31 | $48.28 Million | +1010.50% |
| 2013-03-31 | $-5.30 Million | -82539.86% |
| 2012-03-31 | $-6.42K | 0.00% |
| 2011-03-31 | $-6.42K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Organovo Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 33948325800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.00K | 0.28% |
| Other Components | $343.26 Million | 9532.35% |
| Total Equity | $3.60 Million | 100.00% |
Organovo Holdings Inc Competitors by Market Cap
The table below lists competitors of Organovo Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Golden Tobacco Limited
NSE:GOLDENTOBC
|
$2.41 Million |
|
Rani Zim Shopping Centers
TA:RANI
|
$2.41 Million |
|
Panca Mitra Multiperdana Tbk PT
JK:PMMP
|
$2.41 Million |
|
Permsin Steel Works Public Company Limited
BK:PERM
|
$2.41 Million |
|
Goff Corp
PINK:WNFT
|
$2.41 Million |
|
MASTEC (MY8.SG)
STU:MY8
|
$2.40 Million |
|
ClearStream Energy Services Inc
PINK:NWPIF
|
$2.40 Million |
|
Indosterling Technomedia Tbk
JK:TECH
|
$2.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Organovo Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 15,329,000 to 3,601,000, a change of -11,728,000 (-76.5%).
- Net loss of 14,671,000 reduced equity.
- New share issuances of 1,437,000 increased equity.
- Other comprehensive income decreased equity by 2,000.
- Other factors increased equity by 1,508,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.67 Million | -407.41% |
| Share Issuances | $1.44 Million | +39.91% |
| Other Comprehensive Income | $-2.00K | -0.06% |
| Other Changes | $1.51 Million | +41.88% |
| Total Change | $- | -76.51% |
Book Value vs Market Value Analysis
This analysis compares Organovo Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.75x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | $0.00 | $1.87 | x |
| 2012-03-31 | $0.00 | $1.87 | x |
| 2013-03-31 | $-2.46 | $1.87 | x |
| 2014-03-31 | $13.20 | $1.87 | x |
| 2015-03-31 | $12.23 | $1.87 | x |
| 2016-03-31 | $13.46 | $1.87 | x |
| 2017-03-31 | $12.76 | $1.87 | x |
| 2018-03-31 | $8.31 | $1.87 | x |
| 2019-03-31 | $6.29 | $1.87 | x |
| 2020-03-31 | $4.11 | $1.87 | x |
| 2021-03-31 | $5.68 | $1.87 | x |
| 2022-03-31 | $3.47 | $1.87 | x |
| 2023-03-31 | $1.76 | $1.87 | x |
| 2024-03-31 | $0.39 | $1.87 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Organovo Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -407.41%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13459.63%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 1.76x
- Recent ROE (-407.41%) is below the historical average (-75.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-147.18K |
| 2012 | 0.00% | -15.24% | 226.90x | 0.00x | $-147.18K |
| 2013 | 0.00% | -3638.51% | 0.07x | 0.00x | $-43.02 Million |
| 2014 | -53.53% | -6820.05% | 0.01x | 1.04x | $-30.68 Million |
| 2015 | -61.78% | -5268.30% | 0.01x | 1.10x | $-34.95 Million |
| 2016 | -62.04% | -2601.15% | 0.02x | 1.09x | $-44.79 Million |
| 2017 | -61.65% | -908.91% | 0.06x | 1.11x | $-44.68 Million |
| 2018 | -78.06% | -756.09% | 0.09x | 1.12x | $-39.26 Million |
| 2019 | -73.38% | -861.70% | 0.08x | 1.12x | $-30.26 Million |
| 2020 | -70.26% | -852.00% | 0.08x | 1.07x | $-21.37 Million |
| 2021 | -42.93% | 0.00% | 0.00x | 1.02x | $-20.75 Million |
| 2022 | -37.90% | -763.20% | 0.05x | 1.10x | $-14.47 Million |
| 2023 | -112.59% | -4664.59% | 0.02x | 1.33x | $-18.79 Million |
| 2024 | -407.41% | -13459.63% | 0.02x | 1.76x | $-15.03 Million |
Industry Comparison
This section compares Organovo Holdings Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Organovo Holdings Inc (ONVO) | $364.00K | 0.00% | 9.56x | $2.41 Million |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |